Comparison of Therapy in Advanced Hepatocellular Carcinoma Based on Clear Definition and Accurate Subgroup Data

JAMA Oncol. 2021 Jun 1;7(6):940-941. doi: 10.1001/jamaoncol.2021.0531.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / therapy
  • Combined Modality Therapy
  • Humans
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / therapy
  • Sorafenib

Substances

  • Sorafenib